Phase
Condition
N/ATreatment
PARTNER intervention
Control intervention
Clinical Study ID
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged 65 years or older
Patient is capable of giving consent
GP contact in the quarter prior to inclusion
Current use of ≥ 5 drugs, including ≥ 1 PSA-PIM (hypnotics, opioids, gabapentinoids,antipsychotics, antidepressants, anticholinergic urospasmolytics) with a treatmentduration of ≥ 6 months
Willingness to select a regular pharmacy for the study period
Consent to data exchange between GP and community pharmacy
Exclusion
Exclusion Criteria:
Terminal illness (life expectancy < 6 months)
Current treatment of pain associated with cancer
Other serious physical illness or mental distress (e.g. bereavement) that makesparticipation in the study impossible (according to the GP's assessment)
Psychiatric illness or addiction that makes participation in the study impossible (according to the GP's assessment)
Unable to meet the requirements of the study (participation in telephone or writtenquestionnaires, visits to the GP practice or community pharmacy, alone or with thehelp of caregivers for physical infirmity)
Current participation in research projects on medication safety or geriatricmedicine
Study Design
Connect with a study center
University of Bielefeld
Bielefeld, 33615
GermanySite Not Available
University Hospital, LMU Munich
Munich, 80336
GermanyActive - Recruiting
Witten/Herdecke University
Witten, 58448
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.